CONMED Corp — Director's Dealing 2018

Feb 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-02-01

Reporting Person: GOLDEN JO ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	Common Stock	S	3000	$63.898	Disposed	16782	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.88 to $63.94. Full information regarding the number of shares sold at each price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.